EcoDrugPlus

Integrin Subunit Beta 6

Ensembl ID : ENSSLUG00000020139
Gene Symbol: ITGB6
1 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSSLUG00000019534
Gene Symbol: ITGB8
1 Cross references
202 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSSLUG00000014642
Gene Symbol: ITGAV
1 Cross references
237 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSSLUG00000020388
Gene Symbol: ITGB5
1 Cross references
205 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSSLUG00000005222
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSSLUG00000024221
Gene Symbol: LOC116040543
2 Cross references
183 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSSLUG00000019425
Gene Symbol: LOC116061390
3 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSSLUG00000014916
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSSLUG00000007447
Gene Symbol: LOC116038731
3 Cross references
207 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSSLUG00000024692
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSSLUG00000011959
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSSLUG00000015492
Gene Symbol: KIF11
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).